| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 131.446 | 234.331 | 317.875 | 537.517 | 419.125 | 108.276 | 0 | 0 |
| Total Income - EUR | - | 289 | 135.056 | 241.510 | 352.056 | 576.753 | 447.431 | 150.172 | 0 | 10.641 |
| Total Expenses - EUR | - | 5.926 | 45.661 | 40.023 | 154.278 | 73.855 | 34.422 | 51.087 | 14.802 | 15.509 |
| Gross Profit/Loss - EUR | - | -5.636 | 89.395 | 201.487 | 197.778 | 502.898 | 413.010 | 99.085 | -14.802 | -4.868 |
| Net Profit/Loss - EUR | - | -6.546 | 85.448 | 194.375 | 194.583 | 497.910 | 408.818 | 98.091 | -14.802 | -4.868 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 0 |
Check the financial reports for the company - Neogenomics Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 30.345 | 120.985 | 313.733 | 503.456 | 1.001.842 | 1.404.777 | 1.492.543 | 1.266.675 | 890.986 |
| Inventories | - | 0 | 6.180 | 52.287 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 30.336 | 98.750 | 203.610 | 469.119 | 739.548 | 916.994 | 1.021.865 | 545.891 | 880.887 |
| Cash | - | 9 | 16.055 | 57.836 | 34.337 | 262.294 | 487.783 | 470.677 | 720.784 | 10.099 |
| Shareholders Funds | - | -6.502 | 79.100 | 272.024 | 461.339 | 950.503 | 1.338.243 | 1.440.486 | 1.214.463 | 858.349 |
| Social Capital | - | 45 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | 36.847 | 42.004 | 41.816 | 42.638 | 51.375 | 66.534 | 52.057 | 52.212 | 32.637 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Neogenomics Srl